Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12620000498998
Ethics application status
Approved
Date submitted
15/04/2020
Date registered
20/04/2020
Date last updated
20/04/2020
Date data sharing statement initially provided
20/04/2020
Type of registration
Prospectively registered
Titles & IDs
Public title
Retrospective Study on surgical outcomes among surgical patients during the COVID-19 (SARS-CoV-2) Pandemic
Query!
Scientific title
Retrospective cohort study of COVID-19 infection among surgical patients after surgery
Query!
Secondary ID [1]
301017
0
None
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
SARS-CoV-2 Positive
317057
0
Query!
Scheduled surgery
317058
0
Query!
Emergency surgery
317059
0
Query!
Condition category
Condition code
Respiratory
315222
315222
0
0
Query!
Other respiratory disorders / diseases
Query!
Infection
315223
315223
0
0
Query!
Other infectious diseases
Query!
Surgery
315224
315224
0
0
Query!
Other surgery
Query!
Intervention/exposure
Study type
Observational
Query!
Patient registry
False
Query!
Target follow-up duration
Query!
Target follow-up type
Query!
Description of intervention(s) / exposure
incidence of Sars-COV-2 infection in patients undergoing surgery from Feburary 2020 to April 2020
No involvment for the patients, and the medical charts will be review to gather informations needed.
For each participant medical chart will be check 2 weeks after surgery or at the date of hospital discharge if their hospital stay is longer than two weeks
Query!
Intervention code [1]
317332
0
Not applicable
Query!
Comparator / control treatment
No control group
Query!
Control group
Uncontrolled
Query!
Outcomes
Primary outcome [1]
323479
0
Incidence of Sars-COV-2 infection during hospital stay :
- positive rt-PCR or high clinical suspicion with typical parenchymal lesion
Query!
Assessment method [1]
323479
0
Query!
Timepoint [1]
323479
0
From day of surgery until 2 weeks post operative. If hospital stay exceeds 2 weeks, it'll be assess at hospital discharge
Query!
Secondary outcome [1]
382024
0
Death of surgical patients with Sars-COV-2 infection
SARS-COV-2 assessment ::
- positive rt-PCR or high clinical suspicion with typical parenchymal lesion
Query!
Assessment method [1]
382024
0
Query!
Timepoint [1]
382024
0
from day of surgery until discharge or death (information will be gathered from medical chart)
Query!
Eligibility
Key inclusion criteria
Adult (18+ years old) patients undergoing surgery
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Pre operative confirmed Sars-COV-2 infection
Query!
Study design
Purpose
Natural history
Query!
Duration
Longitudinal
Query!
Selection
Defined population
Query!
Timing
Retrospective
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Not yet recruiting
Query!
Date of first participant enrolment
Anticipated
22/04/2020
Query!
Actual
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
700
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
22493
0
France
Query!
State/province [1]
22493
0
Query!
Funding & Sponsors
Funding source category [1]
305461
0
Hospital
Query!
Name [1]
305461
0
Anesthesiology Intensive Care and peri operative medicine department, Tenon hospital
Query!
Address [1]
305461
0
4 rue de la Chine
75020 Paris
France
Query!
Country [1]
305461
0
France
Query!
Primary sponsor type
Hospital
Query!
Name
Anesthesiology Intensive Care and peri operative medicine department, Tenon hospital
Query!
Address
4 rue de la Chine
75020 Paris
France
Query!
Country
France
Query!
Secondary sponsor category [1]
305858
0
None
Query!
Name [1]
305858
0
Query!
Address [1]
305858
0
Query!
Country [1]
305858
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
305776
0
Comité d’éthique pour la recherche en Anesthésie-Réanimation (French IRB)
Query!
Ethics committee address [1]
305776
0
74 rue Raynouard 75016 Paris FRANCE
Query!
Ethics committee country [1]
305776
0
France
Query!
Date submitted for ethics approval [1]
305776
0
03/04/2020
Query!
Approval date [1]
305776
0
06/04/2020
Query!
Ethics approval number [1]
305776
0
IRB 00010254 -- 2020 -- 054
Query!
Summary
Brief summary
On March 11, 2020, WHO declared that the COVID-19 epidemic had become a pandemic. Health authorities around the word are taking measures to increase conventional hospitalization and intensive care capacity. So, the way surgery is performed have changed. Emergency surgery remains a priority, and functional surgery has to be postponed. The main question concerns oncological surgery, operate or postpone? There is probably a risk induced by the pandemic COVID 19 which must be balanced against the oncological risk linked to delay in surgery. A Chinese report described that cancer patients are more likely to develop infection by the virus due to their immunosuppression secondary to cancer, chemotherapy and surgery. This article also highlights that these patients are at higher risk of developing severe episodes (39% vs 8%). Patients who underwent surgery or received chemotherapy in the month before the virus appeared had a greater risk (75%) of developing a severe episode than those who did not undergo surgery or did not receive chemotherapy (43%). The objective of our report is to share our experience of performing scheduled and urgent surgery in COVID-19 pandemic. We report the perioperative characteristics and outcome of patients in whom surgery was undertaken.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
101558
0
Dr Julien BUREY
Query!
Address
101558
0
Département d'anesthésie, réanimation et médecine péri opératoire
4 rue de la chine
75020 Paris
France
Query!
Country
101558
0
France
Query!
Phone
101558
0
+33156017898
Query!
Fax
101558
0
Query!
Email
101558
0
[email protected]
Query!
Contact person for public queries
Name
101559
0
Julien BUREY
Query!
Address
101559
0
Département d'anesthésie, réanimation et médecine péri opératoire
4 rue de la chine
75020 Paris
France
Query!
Country
101559
0
France
Query!
Phone
101559
0
+33156017898
Query!
Fax
101559
0
Query!
Email
101559
0
[email protected]
Query!
Contact person for scientific queries
Name
101560
0
Christophe QUESNEL
Query!
Address
101560
0
Département d'anesthésie, réanimation et médecine péri opératoire
4 rue de la chine
75020 Paris
France
Query!
Country
101560
0
France
Query!
Phone
101560
0
+33156017898
Query!
Fax
101560
0
Query!
Email
101560
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
Extracted data detailing sex, age, operation type, clinical characteristics (including symptoms/signs, blood test results, and throat swab nucleic acid), and type of surgery from electronic medical records.
Lymphocytes, Platets and haemoglobin counts after surgery were also recorded.
All the data will be shared.
Query!
When will data be available (start and end dates)?
From 1st of June 2020 to 1st of June 2021
Query!
Available to whom?
case-by-case basis at the discretion of Primary Sponsor
Query!
Available for what types of analyses?
for IPD meta-analyses
Query!
How or where can data be obtained?
On demand by emailing the Primary Sponsor
Enquiries should be directed to
[email protected]
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF